6533b830fe1ef96bd1297106
RESEARCH PRODUCT
Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine
G CiusaF Guida MarasciaR VirrusoA AnghebenG GuaraldiA Casciosubject
Plasmodium malariaeInfectious DiseasesPlasmodium malariae.BNT162b2Chronic malariaBNT162b2; Chronic malaria; CoVID-19 vaccine; Malaria; Plasmodium malariaeCoVID-19 vaccineMalariadescription
We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated to splenomegaly, the onset of the fever occurred one month after CoVID-19 vaccination with BNT162b2. P. malariae was diagnosed using CarestartTM malaria rapid test and Polymerase-Chain Reaction. Post-vaccine transient reduction of immune reactivity is described in literature, although the mechanism is unknown.(c) 2022 Published by Elsevier Ltd.CC_BY_NC_ND_4.0
year | journal | country | edition | language |
---|---|---|---|---|
2022-01-01 | IDCases |